Fulvestrant (Faslodex) for advanced breast cancer

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2002年 / 44卷 / 1135期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [1] Fulvestrant injection (Faslodex) - Additional treatment for advanced breast cancer
    不详
    AMERICAN JOURNAL OF NURSING, 2002, 102 (08) : 24CCC - 24CCC
  • [2] Case studies of fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer
    Abram, P
    Maass, N
    Rea, D
    Simon, SD
    Steger, GG
    CANCER TREATMENT REVIEWS, 2005, 31 : S17 - S25
  • [3] Fulvestrant (Faslodex™) in advanced breast cancer:: clinical experience from a Belgian cooperative study
    Neven, Patrick
    Paridaens, Robert
    Pelgrims, Gino
    Martens, Marc
    Bols, Alain
    Goeminne, Jean Charles
    Vindevoghel, Anita
    Demol, Jan
    Stragier, Barbara
    De Greve, Jacques
    Fontaine, Christel
    Van Den Weyngaert, Danielle
    Becquart, Dominique
    Borms, Marleen
    Cocquyt, Veronique
    Van den Broecke, Rudy
    Selleslags, Jean
    Awada, Ahmad
    Dirix, Luc
    Van Dam, Peter
    Azerad, Marie Agnes
    Vandenhoven, Guy
    Christiaens, Marie Rose
    Vergote, Ignace
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 59 - 65
  • [4] Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study
    Patrick Neven
    Robert Paridaens
    Gino Pelgrims
    Marc Martens
    Alain Bols
    Jean Charles Goeminne
    Anita Vindevoghel
    Jan Demol
    Barbara Stragier
    Jacques De Greve
    Christel Fontaine
    Danielle Van Den Weyngaert
    Dominique Becquart
    Marleen Borms
    Veronique Cocquyt
    Rudy Van Den Broecke
    Jean Selleslags
    Ahmad Awada
    Luc Dirix
    Peter Van Dam
    Marie Agnes Azerad
    Guy Vandenhoven
    Marie Rose Christiaens
    Ignace Vergote
    Breast Cancer Research and Treatment, 2008, 109 : 59 - 65
  • [5] Fulvestrant ('Faslodex'): Current and future role in breast cancer management
    Howell, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (03) : 265 - 273
  • [6] Fulvestrant (Faslodex®) is effective in postmenopausal women with visceral metastases (VM) In advanced breast cancer (ABC)
    Mauriac, L
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S96 - S96
  • [7] Fulvestrant ('Faslodex') in pre-treated patients with advanced breast cancer: A single-centre experience
    Steger, GG
    Bartsch, R
    Wenzel, C
    Pluschni, U
    Hussian, D
    Sevelda, U
    Locker, GJ
    Gnant, MF
    Jakesz, R
    Zielinski, CC
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (17) : 2655 - 2661
  • [8] Evidence of continued sensitivity to endocrine agents in postmenopausal women with advanced breast cancer progressing on fulvestrant ('Faslodex®')
    Vergote, I
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 288 - 288
  • [9] Fulvestrant ('Faslodex®') is effective in advanced breast cancer in postmenopausal patients with visceral metastases:: comparison with anastrazole.
    Mauriac, L
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 289 - 289
  • [10] FULVESTRANT ('FASLODEX'): A NEW OPTION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Kleeberg, Ulrich R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3537 - 3537
12345